Table 2.
Characteristic | Phase A (n=1040) |
Phase B (n =1499) |
Phase C (n =1455) |
P |
---|---|---|---|---|
Total Assessments, n | 699 | 910 | 3546 | |
Assessments Per Patient, mean (SD) | 0.67 (0.8) | 0.61 (0.8) | 2.44 (2.3) | <0.001†,‡ |
Patients with Score ≥4, n (%) | -- | 71 (4.7) | 182 (12.5) | <0.001 |
Score ≥4 Plus Notification, n (%) | -- | 42 (2.8) | 133 (9.1) | <0.001 |
Total Clinician Notifications, n (%) | 84 | 113 | 161 | 0.002†,‡ |
Patients with a clinician notification, % | 8.1 | 7.5 | 11.1 | |
Clinician notifications per total ITAT score assessments, % | 12 | 12.4 | 4.5 | |
Died, n (%) | 97 (9.3) | 85 (5.7) | 100 (6.9) | 0.002* |
Age at Death, median months (IQR) | 20.1 (8.8 – 46.2) | 18.9 (10.2 – 36.5) | 20.3 (10.9 – 33.0) | 0.989 |
Admission to Death, mean days (range) | 1.5 (2 – 18) | 1.6 (0 – 19) | 1.2 (0 – 11) | 0.725 |
Phase A was significantly different than Phase B
Phase A was significantly different than Phase C
Phase B was significantly different than Phase C